D-0353-2016 Class II Terminated

Recalled by Downing Labs, LLC — Dallas, TX

FDA drug recall D-0353-2016 was initiated by Downing Labs, LLC on Oct 16, 2015 and is designated Class II. Reason for recall: Lack of Assurance of Sterility The recall status is terminated (terminated Sep 22, 2016). Affected quantity: 2189 vials.

Recall details

Product Type
Drugs
Report Date
Nov 25, 2015
Initiation Date
Oct 16, 2015
Termination Date
Sep 22, 2016
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
2189 vials

Product description

Phosphatidylcholine/Deoxycholic Acid Injection (Preserved) 50 ML 10/4.75%; Phosphatidylcholine/Deoxycholic Acid Injection (Preserved) 50 ML 5/2.5%; Phosphatidylcholine/Deoxycholic Acid Injection (Preserved) 50 ML 5/4.2%, Rx only, Downing Labs, LLC 4001 McEwen Rd, Suite 110, Dallas TX, 754244, 1-800-914-7435

Reason for recall

Lack of Assurance of Sterility

Distribution pattern

Nationwide in the US; Australia, Brazil, Bahamas, Switzerland, France, Colombia, Hong Kong, Indonesia, India, Japan, Malaysia, New Zealand, Phillippines, Singapore, Thailand, Trinidad and Tobago, Taiwan

Code information

All lots

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0353-2016
openFDA file date
Nov 19, 2026
Loaded by RegDataLab
Nov 20, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Need the full FDA record for Downing Labs, LLC? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: openFDA record for D-0353-2016. Report a data issue: hello@regdatalab.com.